Clinical Trials Directory

Trials / Unknown

UnknownNCT03671798

Establish a National Registry of REM Sleep Behavior Disorder

Establish a National Registry to Search for the Risk Factors, Etiology, and Neurodegenerative Progression of REM Sleep Behavior Disorder

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

In this proposed study, the investigators aim to build up a large cohort of Rapid eye movement sleep behavior disorder (RBD) to study the etiology and risk factors of neurodegeneration.

Detailed description

REM sleep behavior disorder (RBD) is a parasomnia characterized by abnormal behavioral manifestations during REM sleep. Accumulating evidence suggests that RBD is implicated as an integral part of disease progress of α-synucleinopathy neurodegeneration, such as Parkinson's disease (PD) and dementia with Lewy bodies.Previous studies have identified a series of neurocognitive, autonomic, clinical and neurobiological markers for neurodegeneration in iRBD, such as olfactory dysfunction, color vision deficit, autonomic dysfunction, tonic EMG activity during REM sleep, and psychiatric disorder. However, the prevalence rate of RBD was relatively low and most of the RBD studies only have 100 or below cases. and there might be ethic differences in RBD which indicates that the findings from western countries might not be applicable to Chinese. In these regards, the investigators aimed to build up a large cohort of Rapid eye movement sleep behavior disorder (RBD) to study the etiology and risk factors of neurodegeneration.

Conditions

Timeline

Start date
2014-10-01
Primary completion
2022-04-01
Completion
2022-04-01
First posted
2018-09-14
Last updated
2021-08-06

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03671798. Inclusion in this directory is not an endorsement.